CoreCap Advisors »

Immunovant shares owned by CoreCap Advisors

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by CoreCap Advisors from 13F filings

Historical chart of CoreCap Advisors investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by CoreCap Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by CoreCap Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $270k 6.4k 42.13
2023-09-30 $221k 5.8k 38.39
2023-06-30 $292k 15k 18.97

More positions owned by CoreCap Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core S&p500 Etf (IVV)
Select Sector Spdr Tr Technology (XLK)
Spdr Ser Tr Portfolio Ln Tsr (SPTL)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Spdr Ser Tr Portfolio Short (SPSB)

View all positions for CoreCap Advisors

Top funds holding Immunovant

Vanguard Group
Point72 Asset Management
Perceptive Advisors
T. Rowe Price Associates
Alpine Partners VI
Logos Global Management
Cormorant Asset Management
Citadel Advisors
Commodore Capital
Boxer Capital
Redmile Group
Fred Alger Management
Millennium Management
Dimensional Fund Advisors
Ikarian Capital

View all funds holding Immunovant